Plasma activity of the enzyme N-acetil-beta-glucosaminidase in healthy and diabetic subjects: effects of treatment with a sulfonylurea drug.
Giraudo
J R
JR
Instituto Modelo de Diabetes Endocrinologia y Nutricion, Cordoba, Argentina.
Fugante
M
M
Blaque Quadri
J
J
Reyes
G
G
Duran Saucedo
N
N
D000118:Acetylglucosaminidase / Q000097:blood*; D000328:Adult; D048909:Diabetes Complications; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy; D005260:Female; D005907:Gliclazide / Q000627:therapeutic use*; D006596:Hexosaminidases / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012016:Reference Values; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
D013453:Sulfonylurea Compounds; D006596:Hexosaminidases; D000118:Acetylglucosaminidase; D005907:Gliclazide